Zhang Miao, Zhang Shudong, Wang Lin, Zhang Zhe, Hu Qin, Liu Dongyang
Drug Clinical Trial Center, Peking University Third Hospital, Beijing 100191, China.
Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, MA 02115, USA.
Pharmaceutics. 2024 Oct 12;16(10):1324. doi: 10.3390/pharmaceutics16101324.
: Physiologically based pharmacokinetic (PBPK) absorption models are instrumental for assessing drug absorption prior to clinical food effect studies, though discrepancies in predictive and actual outcomes are observed. This study focused on immediate release formulations of weakly basic water-insoluble compounds, namely rivaroxaban, ticagrelor, and PB-201, to investigate factors that could improve the predictive accuracy of PBPK models regarding food effects. : Comprehensive in vitro experimental results provided the basis for the development of mechanistic absorption models, which were then combined with mechanistic disposition models to predict the systemic exposure of the model drugs in both fasted and fed states. : The developed PBPK models showed moderate to high predictive accuracy for food effects in Caucasian populations. For the Chinese population, the ticagrelor model's initial overestimation of fed-state absorption was addressed by updating the permeability parameters from Caco-2 cell assays to those derived from parallel artificial membrane permeability assays in FaSSIF and FeSSIF media. This refinement was also applied to the rivaroxaban and ticagrelor models, leading to a more accurate representation of absorption in Caucasians. : This study highlights the importance of apparent permeability in enhancing the predictive accuracy of PBPK absorption models for weakly basic water-insoluble compounds. Furthermore, the precipitation of PB-201 in the two-stage transfer experiments suggests that precipitation may not be a universal phenomenon for such compounds in vivo. Consequently, the precipitation rate constant, a theoretically essential parameter, should be determined based on experimental evidence to avoid overparameterization and ensure robust predictive accuracy of PBPK models.
基于生理的药代动力学(PBPK)吸收模型对于在临床食物效应研究之前评估药物吸收很有帮助,尽管观察到预测结果与实际结果存在差异。本研究聚焦于弱碱性水不溶性化合物利伐沙班、替格瑞洛和PB - 201的速释制剂,以研究可提高PBPK模型对食物效应预测准确性的因素。:全面的体外实验结果为构建机制性吸收模型提供了基础,该模型随后与机制性处置模型相结合,以预测模型药物在禁食和进食状态下的全身暴露情况。:所构建的PBPK模型对高加索人群的食物效应显示出中等到较高的预测准确性。对于中国人群,替格瑞洛模型最初对进食状态下吸收的高估通过将Caco - 2细胞试验的渗透性参数更新为在FaSSIF和FeSSIF介质中平行人工膜渗透性试验得出的参数得以解决。这一改进也应用于利伐沙班和替格瑞洛模型,从而更准确地反映了高加索人群的吸收情况。:本研究强调了表观渗透性在提高PBPK对弱碱性水不溶性化合物吸收模型预测准确性方面的重要性。此外,PB - 201在两阶段转运实验中的沉淀表明,沉淀可能并非此类化合物在体内的普遍现象。因此,沉淀速率常数这一理论上的关键参数应根据实验证据来确定,以避免过度参数化并确保PBPK模型具有稳健的预测准确性。